SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001144204-11-050977
Filing Date
2011-09-01
Accepted
2011-09-01 15:37:39
Documents
7
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A v233964_10qa.htm 10-Q/A 31878
  Complete submission text file 0001144204-11-050977.txt   1057534

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT gnpb-20110630.xml EX-101.INS 140962
3 XBRL TAXONOMY EXTENSION SCHEMA gnpb-20110630.xsd EX-101.SCH 12629
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gnpb-20110630_cal.xml EX-101.CAL 23506
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpb-20110630_def.xml EX-101.DEF 16735
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpb-20110630_lab.xml EX-101.LAB 79366
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpb-20110630_pre.xml EX-101.PRE 60668
Mailing Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266
Business Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266 866-963-2220
Genesis Biopharma, Inc (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-53127 | Film No.: 111070982
SIC: 4731 Arrangement of Transportation of Freight & Cargo